trending Market Intelligence /marketintelligence/en/news-insights/trending/dnBEGkSu4SzQRJ-eVAz74Q2 content esgSubNav
In This List

Vanc Pharmaceuticals CEO resigns; interim named

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Vanc Pharmaceuticals CEO resigns; interim named

Vanc Pharmaceuticals Inc. CEO Arun Nayyar resigned, effective immediately.

Bob Rai replaced Nayyar on an interim basis. Rai, who has been a director at Vanc since June 2015, is chairman and CEO of Canada Pacific Global Pharmaceuticals.